IN192180B - - Google Patents

Info

Publication number
IN192180B
IN192180B IN1002DE2001A IN192180B IN 192180 B IN192180 B IN 192180B IN 1002DE2001 A IN1002DE2001 A IN 1002DE2001A IN 192180 B IN192180 B IN 192180B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Deepak Murpani
Ashish Madan
Vinod Kumar Arora
Rajiv Malik
Original Assignee
Ranbaxy Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab filed Critical Ranbaxy Lab
Priority to IN1002DE2001 priority Critical patent/IN192180B/en
Priority to EP02800214A priority patent/EP1434568A1/de
Priority to PCT/IB2002/003997 priority patent/WO2003028704A1/en
Priority to CNA02822180XA priority patent/CN1582145A/zh
Priority to KR10-2004-7004586A priority patent/KR20040063900A/ko
Priority to BR0212931-0A priority patent/BR0212931A/pt
Priority to EA200400487A priority patent/EA200400487A1/ru
Priority to JP2003532037A priority patent/JP2005507896A/ja
Priority to US10/432,654 priority patent/US20040059001A1/en
Priority to MXPA04002910A priority patent/MXPA04002910A/es
Priority to ARP020103687A priority patent/AR037326A1/es
Publication of IN192180B publication Critical patent/IN192180B/en
Priority to ZA200402532A priority patent/ZA200402532B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IN1002DE2001 2001-09-28 2001-09-28 IN192180B (de)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IN1002DE2001 IN192180B (de) 2001-09-28 2001-09-28
BR0212931-0A BR0212931A (pt) 2001-09-28 2002-09-27 Composição farmacêutica de liberação prolongada contendo metformina
PCT/IB2002/003997 WO2003028704A1 (en) 2001-09-28 2002-09-27 Extended release pharmaceutical composition containing metformin
CNA02822180XA CN1582145A (zh) 2001-09-28 2002-09-27 含有二甲双胍的缓释药物组合物
KR10-2004-7004586A KR20040063900A (ko) 2001-09-28 2002-09-27 메트포르민을 함유하는 서방 약학 조성물
EP02800214A EP1434568A1 (de) 2001-09-28 2002-09-27 Metformin enthaltende pharmazeutische zusammensetzung mit verlängerter freisetzung
EA200400487A EA200400487A1 (ru) 2001-09-28 2002-09-27 Фармацевтическая композиция длительного высвобождения, содержащая метформин
JP2003532037A JP2005507896A (ja) 2001-09-28 2002-09-27 メトフォルミン含有放出延長型医薬組成物
US10/432,654 US20040059001A1 (en) 2001-09-28 2002-09-27 Extended release pharmaceutical composition containing metformin
MXPA04002910A MXPA04002910A (es) 2001-09-28 2002-09-27 Composicion farmaceutica de liberacion prolongada que contiene metformin.
ARP020103687A AR037326A1 (es) 2001-09-28 2002-09-30 Composicion farmaceutica de liberacion prolongada que contiene metformina
ZA200402532A ZA200402532B (en) 2001-09-28 2004-03-31 Extended release pharmaceutical composition containing metformin.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1002DE2001 IN192180B (de) 2001-09-28 2001-09-28

Publications (1)

Publication Number Publication Date
IN192180B true IN192180B (de) 2004-03-06

Family

ID=11097117

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1002DE2001 IN192180B (de) 2001-09-28 2001-09-28

Country Status (12)

Country Link
US (1) US20040059001A1 (de)
EP (1) EP1434568A1 (de)
JP (1) JP2005507896A (de)
KR (1) KR20040063900A (de)
CN (1) CN1582145A (de)
AR (1) AR037326A1 (de)
BR (1) BR0212931A (de)
EA (1) EA200400487A1 (de)
IN (1) IN192180B (de)
MX (1) MXPA04002910A (de)
WO (1) WO2003028704A1 (de)
ZA (1) ZA200402532B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911781B2 (en) 2002-06-17 2014-12-16 Inventia Healthcare Private Limited Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides
CN1805738A (zh) * 2003-06-16 2006-07-19 兰贝克赛实验室有限公司 持续释放的二甲双胍片剂
WO2005092293A1 (en) * 2004-03-22 2005-10-06 Ranbaxy Laboratories Limited Formulations of metformin
EP1814528A2 (de) * 2004-10-08 2007-08-08 Rubicon Research Private Limited Verfahren zur herstellung einer stark komprimierbaren metforminzusammensetzung mit kontrollierter freisetzung
RS51271B (sr) * 2004-10-19 2010-12-31 Krka Tovarna Zdravil D.D. Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid
US20090124702A1 (en) * 2005-01-25 2009-05-14 Pechetti Siva Satya Krishna Babu Pharmaceutical Compositions of Metformin
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
WO2006122021A1 (en) * 2005-05-10 2006-11-16 Novartis Ag Extrusion process for making compositions with poorly compressible therapeutic compounds
KR100780553B1 (ko) * 2005-08-18 2007-11-29 한올제약주식회사 메트포르민 서방정 및 그의 제조방법
CN101299993A (zh) * 2005-11-04 2008-11-05 伊士曼化工公司 用于给药难溶的药学活性剂的羧烷基纤维素酯
BRPI0605967A (pt) * 2006-12-20 2008-08-12 Medley S A Ind Farmaceutica composição farmacêutica de liberação controlada, forma farmacêutica de liberação controlada e processo para obtenção de forma farmacêutica
EP2109447B1 (de) 2007-01-29 2015-06-10 HanAll Biopharma Co., Ltd. N,n-dimethyl-imidodicarbonimid-diamid-acetat, verfahren zu seiner herstellung und pharmazeutische zusammensetzungen damit
KR101597004B1 (ko) 2013-07-25 2016-02-23 씨제이헬스케어 주식회사 서방형 메트포르민과 속방형 HMG-CoA 환원효소 억제제를 포함하는 복합제제
CN106138020A (zh) * 2015-04-03 2016-11-23 中国人民解放军第三军医大学第三附属医院 双胍类药物在制备预防或减弱肺纤维化的药物中的应用
CN107049980A (zh) * 2017-04-01 2017-08-18 重庆康刻尔制药有限公司 一种盐酸二甲双胍缓释片及其制备方法
WO2021133046A1 (ko) * 2019-12-23 2021-07-01 주식회사 대웅제약 메트포르민 서방성 제제 및 이의 제조 방법
CN111588701B (zh) * 2020-05-25 2021-04-23 上海普康药业有限公司 一种盐酸二甲双胍缓释片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813064D0 (en) * 1988-06-02 1988-07-06 Euro Celtique Sa Controlled release dosage forms having defined water content
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
DE4432757A1 (de) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
JP4278863B2 (ja) * 1997-12-08 2009-06-17 ブリストル−マイヤーズ スクイブ カンパニー メトホルミンの新規塩および方法
EP2332522A3 (de) * 1998-03-19 2011-12-07 Bristol-Myers Squibb Company Zweiphasig kontrolliertes Verabreichungssystem für hochlösliche Arzneimittel und verwandtes Verfahren
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets

Also Published As

Publication number Publication date
WO2003028704A1 (en) 2003-04-10
AR037326A1 (es) 2004-11-03
EP1434568A1 (de) 2004-07-07
US20040059001A1 (en) 2004-03-25
KR20040063900A (ko) 2004-07-14
CN1582145A (zh) 2005-02-16
ZA200402532B (en) 2005-01-04
JP2005507896A (ja) 2005-03-24
EA200400487A1 (ru) 2004-10-28
MXPA04002910A (es) 2004-07-05
BR0212931A (pt) 2004-10-13

Similar Documents

Publication Publication Date Title
BE2022C531I2 (de)
BE2022C547I2 (de)
BE2017C055I2 (de)
BE2017C051I2 (de)
BE2017C032I2 (de)
BE2016C051I2 (de)
BE2015C077I2 (de)
BE2015C046I2 (de)
BE2014C052I2 (de)
BE2014C036I2 (de)
BE2014C026I2 (de)
BE2014C004I2 (de)
BE2014C006I2 (de)
BE2017C050I2 (de)
BE2011C034I2 (de)
BE2007C047I2 (de)
AU2002307149A8 (de)
BRPI0209186B1 (de)
JP2002231952A5 (de)
BE2014C008I2 (de)
CH1379220H1 (de)
BRPI0204884B1 (de)
BE2016C021I2 (de)
IN192180B (de)
BRPI0101486B8 (de)